El Said Ahmed Mohamed, Chase David, Al Rawahy Najib Zahran
Cardiology Department, National Heart Center, Muscat, Oman.
Oman Med J. 2018 Nov;33(6):531-534. doi: 10.5001/omj.2018.97.
Mitral valve regurgitation (MR) is a common problem in patients with cardiac issues especially those with dilated cardiomyopathy (DCM) due to mitral annular dilatation and malcoaptation of the mitral valve leaflets. Although DCM is associated with high mortality rates, there has been no global agreement about the best method of treatment. Treatment of MR in such cases can be done by surgery, which has many limitations due to high-risk concerns. MR may also be managed by other alternatives such as mitral-clip and transcoronary venous mitral annuloplasty using the Carillon® Mitral Contour System®. Combined therapy with a cardiac resynchronization therapy defibrillator (CRT-D) and mitral contour can be used in such cases with valuable improvement in general condition in many patients. In our case, we used the Carillon Mitral Contour System for treatment of severe MR in a 64-year-old patient with severely impaired systolic function after implantation of a CRT-D.
二尖瓣反流(MR)是心脏疾病患者中常见的问题,尤其是那些因二尖瓣环扩张和二尖瓣叶对合不良而患有扩张型心肌病(DCM)的患者。尽管DCM与高死亡率相关,但对于最佳治疗方法尚未达成全球共识。在这种情况下,MR的治疗可以通过手术进行,但由于高风险问题,手术有许多局限性。MR也可以通过其他替代方法进行管理,例如使用Carillon®二尖瓣轮廓系统®的二尖瓣夹合术和经冠状静脉二尖瓣环成形术。心脏再同步化治疗除颤器(CRT-D)和二尖瓣轮廓的联合治疗可用于此类病例,许多患者的总体状况有了显著改善。在我们的病例中,我们使用Carillon二尖瓣轮廓系统对一名64岁收缩功能严重受损且已植入CRT-D的患者进行严重MR的治疗。